Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 SEK | +7.21% | -1.67% | -5.30% |
05-23 | Cantargia Presents New Positive Clinical Data on Nadunolimab Counteracting Chemotherapy Induced Neuropathy | CI |
05-21 | Transcript : Cantargia AB, Q1 2024 Earnings Call, May 21, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CANTARGIA AB | Bio Therapeutic Drugs | +7.21% | -1.67% | -5.30% | -22.44% | -80.42% | 61.07M |
- Stock Market
- Equities
- CANTA Stock
- Charts Cantargia AB
- Relative Strength Chart